Skip to main content
Figure 2 | Basic and Clinical Andrology

Figure 2

From: Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

Figure 2

Mean sexual and hormone domain scores including summary score and subscale scores. Values are expressed as means ± SD, and pretreatment values are compared with those at each post-treatment sampling point. A difference was considered to be significant if the p-value was less than 0.05 (# p < 0.05, * p < 0.01). EPIC: Expanded Prostate Cancer Index Composite. PRE: pretreatment, 6Mo: 6 months after initiation of treatment, 12Mo: 12 months after initiation of treatment Summary score: S; sexual summary score including sexual function and sexual bother scores. H; hormone summary score including hormone function and hormone bother scores. Subscale scores: SF; sexual function, SB; sexual bother, HF; hormonal function, HB; hormone bother.

Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190